Autoimmune Disorders Treatment Market Report

China Autoimmune Disorders Treatment Industry Market Research Report 2023-2029

  • POSTDATE：Sep 14, 2023
  • PAGES：223
  • REPORT CODE：GMM1797381
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Autoimmune Disorders Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Biogen

    • Chugai Pharmaceutical Co, Ltd

    • Eli Lilly and Company

    • Beckman Coulter, Inc

    • Pfizer Inc

    • Amgen Inc

    • F Hoffmann-La Roche Ltd

    • Bayer AG

    • Abbott

    • Merck Sharp & Dohme Corp

    • Johnson & Johnson Services, Inc

    • Bristol-Myers Squibb Company

    • Genentech, Inc

    • LUPIN

    • Siemens Healthcare

    • Autoimmune Inc

    By Type:

    • Therapeutic & Monitoring Equipment

    • Diagnostic Equipment

    • Drugs

    By Application:

    • Medical Center

    • Hospital

    • Other

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Autoimmune Disorders Treatment Market Overview 2018-2029

    • 1.1 China Autoimmune Disorders Treatment Industry Development Overview

    • 1.2 China Autoimmune Disorders Treatment Industry Development History

    • 1.3 China Autoimmune Disorders Treatment Industry Market Size (2018-2029)

    • 1.4 China Autoimmune Disorders Treatment Market Analysis by Type from Production Side

      • 1.4.1 China Autoimmune Disorders Treatment Production Volume, Production Value and Growth Rate of Therapeutic & Monitoring Equipment (2018-2029)

      • 1.4.2 China Autoimmune Disorders Treatment Production Volume, Production Value and Growth Rate of Diagnostic Equipment (2018-2029)

      • 1.4.3 China Autoimmune Disorders Treatment Production Volume, Production Value and Growth Rate of Drugs (2018-2029)

    • 1.5 China Autoimmune Disorders Treatment Market Analysis by Application from Consumption End

      • 1.5.1 China Autoimmune Disorders Treatment Sales Volume, Sales Value and Growth Rate of Medical Center (2018-2029)

      • 1.5.2 China Autoimmune Disorders Treatment Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.3 China Autoimmune Disorders Treatment Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • 1.6 China Autoimmune Disorders Treatment Market Analysis by Region

      • 1.6.1 North China Autoimmune Disorders Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Autoimmune Disorders Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Autoimmune Disorders Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Autoimmune Disorders Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Autoimmune Disorders Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Autoimmune Disorders Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Autoimmune Disorders Treatment Market Size and Growth Rate from 2018-2029

    Chapter 2 China Autoimmune Disorders Treatment Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Autoimmune Disorders Treatment Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Autoimmune Disorders Treatment Market Status and Competition Analysis in 2023

      • 2.2.3 China Autoimmune Disorders Treatment Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Autoimmune Disorders Treatment Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Autoimmune Disorders Treatment Industry Development

    Chapter 3 Autoimmune Disorders TreatmentIndustry Chain Analysis

    • 3.1 Autoimmune Disorders Treatment Industry Chain

    • 3.2 Autoimmune Disorders Treatment Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Autoimmune Disorders Treatment Market

    • 3.3 Autoimmune Disorders Treatment Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Autoimmune Disorders Treatment Market

    Chapter 4 China Autoimmune Disorders Treatment Market, by Type

    • 4.1 China Autoimmune Disorders Treatment Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Autoimmune Disorders Treatment Total Production Volume and Growth Rate from Production Side

    • 4.5 China Autoimmune Disorders Treatment Production Volume and Growth Rate, by Type

      • 4.5.1 China Autoimmune Disorders Treatment Production Volume and Growth Rate of Therapeutic & Monitoring Equipment

      • 4.5.2 China Autoimmune Disorders Treatment Production Volume and Growth Rate of Diagnostic Equipment

      • 4.5.3 China Autoimmune Disorders Treatment Production Volume and Growth Rate of Drugs

    Chapter 5 China Autoimmune Disorders Treatment Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Autoimmune Disorders Treatment Total Market Size and Growth Rate from Consumption End

    • 5.5 China Autoimmune Disorders Treatment Market Size and Growth Rate, by Application

      • 5.5.1 China Autoimmune Disorders Treatment Market Size and Growth Rate of Medical Center

      • 5.5.2 China Autoimmune Disorders Treatment Market Size and Growth Rate of Hospital

      • 5.5.3 China Autoimmune Disorders Treatment Market Size and Growth Rate of Other

    Chapter 6 China Autoimmune Disorders Treatment Market, by Region

    • 6.1 China Autoimmune Disorders Treatment Production Volume and Production Value, by Region

    • 6.2 China Autoimmune Disorders Treatment Sales Volume and Sales Value, by Region

    Chapter 7 North China Autoimmune Disorders Treatment Market Analysis

    • 7.1 North China Autoimmune Disorders Treatment Market, by Type

    • 7.2 North China Autoimmune Disorders Treatment Market, by Application

    Chapter 8 Central China Autoimmune Disorders Treatment Market Analysis

    • 8.1 Central China Autoimmune Disorders Treatment Market, by Type

    • 8.2 Central China Autoimmune Disorders Treatment Market, by Application

    Chapter 9 South China Autoimmune Disorders Treatment Market Analysis

    • 9.1 South China Autoimmune Disorders Treatment Market, by Type

    • 9.2 South China Autoimmune Disorders Treatment Market, by Application

    Chapter 10 East China Autoimmune Disorders Treatment Market Analysis

    • 10.1 East China Autoimmune Disorders Treatment Market, by Type

    • 10.2 East China Autoimmune Disorders Treatment Market, by Application

    Chapter 11 Northeast China Autoimmune Disorders Treatment Market Analysis

    • 11.1 Northeast China Autoimmune Disorders Treatment Market, by Type

    • 11.2 Northeast China Autoimmune Disorders Treatment Market, by Application

    Chapter 12 Southwest China Autoimmune Disorders Treatment Market Analysis

    • 12.1 Southwest China Autoimmune Disorders Treatment Market, by Type

    • 12.2 Southwest China Autoimmune Disorders Treatment Market, by Application

    Chapter 13 Northwest China Autoimmune Disorders Treatment Market Analysis

    • 13.1 Northwest China Autoimmune Disorders Treatment Market, by Type

    • 13.2 Northwest China Autoimmune Disorders Treatment Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Biogen

        • 14.1.1 Biogen Company Profile

        • 14.1.2 Biogen Autoimmune Disorders Treatment Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Chugai Pharmaceutical Co, Ltd

        • 14.2.1 Chugai Pharmaceutical Co, Ltd Company Profile

        • 14.2.2 Chugai Pharmaceutical Co, Ltd Autoimmune Disorders Treatment Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Eli Lilly and Company

        • 14.3.1 Eli Lilly and Company Company Profile

        • 14.3.2 Eli Lilly and Company Autoimmune Disorders Treatment Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Beckman Coulter, Inc

        • 14.4.1 Beckman Coulter, Inc Company Profile

        • 14.4.2 Beckman Coulter, Inc Autoimmune Disorders Treatment Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Pfizer Inc

        • 14.5.1 Pfizer Inc Company Profile

        • 14.5.2 Pfizer Inc Autoimmune Disorders Treatment Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Amgen Inc

        • 14.6.1 Amgen Inc Company Profile

        • 14.6.2 Amgen Inc Autoimmune Disorders Treatment Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 F Hoffmann-La Roche Ltd

        • 14.7.1 F Hoffmann-La Roche Ltd Company Profile

        • 14.7.2 F Hoffmann-La Roche Ltd Autoimmune Disorders Treatment Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Bayer AG

        • 14.8.1 Bayer AG Company Profile

        • 14.8.2 Bayer AG Autoimmune Disorders Treatment Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Abbott

        • 14.9.1 Abbott Company Profile

        • 14.9.2 Abbott Autoimmune Disorders Treatment Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Merck Sharp & Dohme Corp

        • 14.10.1 Merck Sharp & Dohme Corp Company Profile

        • 14.10.2 Merck Sharp & Dohme Corp Autoimmune Disorders Treatment Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Johnson & Johnson Services, Inc

        • 14.11.1 Johnson & Johnson Services, Inc Company Profile

        • 14.11.2 Johnson & Johnson Services, Inc Autoimmune Disorders Treatment Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Bristol-Myers Squibb Company

        • 14.12.1 Bristol-Myers Squibb Company Company Profile

        • 14.12.2 Bristol-Myers Squibb Company Autoimmune Disorders Treatment Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Genentech, Inc

        • 14.13.1 Genentech, Inc Company Profile

        • 14.13.2 Genentech, Inc Autoimmune Disorders Treatment Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 LUPIN

        • 14.14.1 LUPIN Company Profile

        • 14.14.2 LUPIN Autoimmune Disorders Treatment Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Siemens Healthcare

        • 14.15.1 Siemens Healthcare Company Profile

        • 14.15.2 Siemens Healthcare Autoimmune Disorders Treatment Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Autoimmune Inc

        • 14.16.1 Autoimmune Inc Company Profile

        • 14.16.2 Autoimmune Inc Autoimmune Disorders Treatment Market Performance

        • 14.16.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Autoimmune Disorders Treatment Industry Research Conclusions

    • 15.2 Autoimmune Disorders Treatment Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Autoimmune Disorders Treatment Industry Market Size (2018-2029)

    • Figure China Autoimmune Disorders Treatment Production Volume, Production Value and Growth Rate of Therapeutic & Monitoring Equipment (2018-2029)

    • Figure China Autoimmune Disorders Treatment Production Volume, Production Value and Growth Rate of Diagnostic Equipment (2018-2029)

    • Figure China Autoimmune Disorders Treatment Production Volume, Production Value and Growth Rate of Drugs (2018-2029)

    • Figure China Autoimmune Disorders Treatment Sales Volume, Sales Value and Growth Rate of Medical Center (2018-2029)

    • Figure China Autoimmune Disorders Treatment Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Autoimmune Disorders Treatment Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure North China Autoimmune Disorders Treatment Market Size and Growth Rate from 2018-2029

    • Figure Central China Autoimmune Disorders Treatment Market Size and Growth Rate from 2018-2029

    • Figure South China Autoimmune Disorders Treatment Market Size and Growth Rate from 2018-2029

    • Figure East China Autoimmune Disorders Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Autoimmune Disorders Treatment Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Autoimmune Disorders Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Autoimmune Disorders Treatment Market Size and Growth Rate from 2018-2029

    • Figure Autoimmune Disorders Treatment Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Autoimmune Disorders Treatment Market Share by Type in 2018

    • Figure China Autoimmune Disorders Treatment Market Share by Type in 2023

    • Figure China Autoimmune Disorders Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Autoimmune Disorders Treatment Production Volume and Growth Rate of Therapeutic & Monitoring Equipment (2018-2023)

    • Figure China Autoimmune Disorders Treatment Production Volume and Growth Rate of Diagnostic Equipment (2018-2023)

    • Figure China Autoimmune Disorders Treatment Production Volume and Growth Rate of Drugs (2018-2023)

    • Figure China Autoimmune Disorders Treatment Market Share by Application in 2018

    • Figure China Autoimmune Disorders Treatment Market Share by Application in 2023

    • Figure China Autoimmune Disorders Treatment Total Market Size and Growth Rate from Consumption End

    • Figure China Autoimmune Disorders Treatment Market Size and Growth Rate of Medical Center (2018-2023)

    • Figure China Autoimmune Disorders Treatment Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Autoimmune Disorders Treatment Market Size and Growth Rate of Other (2018-2023)

    • Table China Autoimmune Disorders Treatment Production Volume by Region (2018-2023)

    • Table China Autoimmune Disorders Treatment Production Volume Share by Region (2018-2023)

    • Figure China Autoimmune Disorders Treatment Production Volume Share by Region (2018-2023)

    • Table China Autoimmune Disorders Treatment Production Value by Region (2018-2023)

    • Table China Autoimmune Disorders Treatment Production Value Share by Region (2018-2023)

    • Figure China Autoimmune Disorders Treatment Production Value Share by Region (2018-2023)

    • Table China Autoimmune Disorders Treatment Sales Volume by Region (2018-2023)

    • Table China Autoimmune Disorders Treatment Sales Volume Share by Region (2018-2023)

    • Figure China Autoimmune Disorders Treatment Sales Volume Share by Region (2018-2023)

    • Table China Autoimmune Disorders Treatment Sales Value by Region (2018-2023)

    • Table China Autoimmune Disorders Treatment Sales Value Share by Region (2018-2023)

    • Figure China Autoimmune Disorders Treatment Sales Value Share by Region (2018-2023)

    • Table North China Autoimmune Disorders Treatment Production Volume by Type (2018-2023)

    • Table North China Autoimmune Disorders Treatment Production Volume Share by Type (2018-2023)

    • Figure North China Autoimmune Disorders Treatment Production Volume Share by Type (2018-2023)

    • Table North China Autoimmune Disorders Treatment Sales Volume by Application (2018-2023)

    • Table North China Autoimmune Disorders Treatment Sales Volume Share by Application (2018-2023)

    • Figure North China Autoimmune Disorders Treatment Sales Volume Share by Application (2018-2023)

    • Table Central China Autoimmune Disorders Treatment Production Volume by Type (2018-2023)

    • Table Central China Autoimmune Disorders Treatment Production Volume Share by Type (2018-2023)

    • Figure Central China Autoimmune Disorders Treatment Production Volume Share by Type (2018-2023)

    • Table Central China Autoimmune Disorders Treatment Sales Volume by Application (2018-2023)

    • Table Central China Autoimmune Disorders Treatment Sales Volume Share by Application (2018-2023)

    • Figure Central China Autoimmune Disorders Treatment Sales Volume Share by Application (2018-2023)

    • Table South China Autoimmune Disorders Treatment Production Volume by Type (2018-2023)

    • Table South China Autoimmune Disorders Treatment Production Volume Share by Type (2018-2023)

    • Figure South China Autoimmune Disorders Treatment Production Volume Share by Type (2018-2023)

    • Table South China Autoimmune Disorders Treatment Sales Volume by Application (2018-2023)

    • Table South China Autoimmune Disorders Treatment Sales Volume Share by Application (2018-2023)

    • Figure South China Autoimmune Disorders Treatment Sales Volume Share by Application (2018-2023)

    • Table East China Autoimmune Disorders Treatment Production Volume by Type (2018-2023)

    • Table East China Autoimmune Disorders Treatment Production Volume Share by Type (2018-2023)

    • Figure East China Autoimmune Disorders Treatment Production Volume Share by Type (2018-2023)

    • Table East China Autoimmune Disorders Treatment Sales Volume by Application (2018-2023)

    • Table East China Autoimmune Disorders Treatment Sales Volume Share by Application (2018-2023)

    • Figure East China Autoimmune Disorders Treatment Sales Volume Share by Application (2018-2023)

    • Table Northeast China Autoimmune Disorders Treatment Production Volume by Type (2018-2023)

    • Table Northeast China Autoimmune Disorders Treatment Production Volume Share by Type (2018-2023)

    • Figure Northeast China Autoimmune Disorders Treatment Production Volume Share by Type (2018-2023)

    • Table Northeast China Autoimmune Disorders Treatment Sales Volume by Application (2018-2023)

    • Table Northeast China Autoimmune Disorders Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Autoimmune Disorders Treatment Sales Volume Share by Application (2018-2023)

    • Table Southwest China Autoimmune Disorders Treatment Production Volume by Type (2018-2023)

    • Table Southwest China Autoimmune Disorders Treatment Production Volume Share by Type (2018-2023)

    • Figure Southwest China Autoimmune Disorders Treatment Production Volume Share by Type (2018-2023)

    • Table Southwest China Autoimmune Disorders Treatment Sales Volume by Application (2018-2023)

    • Table Southwest China Autoimmune Disorders Treatment Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Autoimmune Disorders Treatment Sales Volume Share by Application (2018-2023)

    • Table Northwest China Autoimmune Disorders Treatment Production Volume by Type (2018-2023)

    • Table Northwest China Autoimmune Disorders Treatment Production Volume Share by Type (2018-2023)

    • Figure Northwest China Autoimmune Disorders Treatment Production Volume Share by Type (2018-2023)

    • Table Northwest China Autoimmune Disorders Treatment Sales Volume by Application (2018-2023)

    • Table Northwest China Autoimmune Disorders Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Autoimmune Disorders Treatment Sales Volume Share by Application (2018-2023)

    • Table Biogen Company Profile

    • Table Biogen Autoimmune Disorders Treatment Revenue, Price and Gross (2018-2023)

    • Table Chugai Pharmaceutical Co, Ltd Company Profile

    • Table Chugai Pharmaceutical Co, Ltd Autoimmune Disorders Treatment Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Company Company Profile

    • Table Eli Lilly and Company Autoimmune Disorders Treatment Revenue, Price and Gross (2018-2023)

    • Table Beckman Coulter, Inc Company Profile

    • Table Beckman Coulter, Inc Autoimmune Disorders Treatment Revenue, Price and Gross (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Autoimmune Disorders Treatment Revenue, Price and Gross (2018-2023)

    • Table Amgen Inc Company Profile

    • Table Amgen Inc Autoimmune Disorders Treatment Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Ltd Company Profile

    • Table F Hoffmann-La Roche Ltd Autoimmune Disorders Treatment Revenue, Price and Gross (2018-2023)

    • Table Bayer AG Company Profile

    • Table Bayer AG Autoimmune Disorders Treatment Revenue, Price and Gross (2018-2023)

    • Table Abbott Company Profile

    • Table Abbott Autoimmune Disorders Treatment Revenue, Price and Gross (2018-2023)

    • Table Merck Sharp & Dohme Corp Company Profile

    • Table Merck Sharp & Dohme Corp Autoimmune Disorders Treatment Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Services, Inc Company Profile

    • Table Johnson & Johnson Services, Inc Autoimmune Disorders Treatment Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Company Profile

    • Table Bristol-Myers Squibb Company Autoimmune Disorders Treatment Revenue, Price and Gross (2018-2023)

    • Table Genentech, Inc Company Profile

    • Table Genentech, Inc Autoimmune Disorders Treatment Revenue, Price and Gross (2018-2023)

    • Table LUPIN Company Profile

    • Table LUPIN Autoimmune Disorders Treatment Revenue, Price and Gross (2018-2023)

    • Table Siemens Healthcare Company Profile

    • Table Siemens Healthcare Autoimmune Disorders Treatment Revenue, Price and Gross (2018-2023)

    • Table Autoimmune Inc Company Profile

    • Table Autoimmune Inc Autoimmune Disorders Treatment Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US